Weekly Clinical Updates

Interim Effectiveness of Updated 2023–2024 COVID-19 Vaccines Against COVID-19 | Combined Protection of Vaccination and Nirmatrelvir-ritonavir in Adults | Ivermectin for COVID-19 in Adults in the Community (PRINCIPLE): An Open, Randomised, Controlled, Adaptive Platform | Cognition and Memory after COVID-19 in a Large Community Sample | Prospective Memory Assessment Before and After Covid-19 | What is the Impact of Long-term COVID-19 on Workers

Effectiveness of Nirmatrelvir-ritonavir on Severe Outcomes of COVID-19 in the Era of Vaccination | Randomized Controlled Trial of Molnupiravir SARS-CoV-2 Viral and Antibody Response | Spontaneous, Persistent, T cell–dependent IFN-γ Release in Patients | Blood–brain Barrier Disruption and Sustained Systemic Inflammation in Individuals | Prevalence of Persistent SARS-CoV-2 in a Large Community Surveillance Study | Long Term Outcomes of Hyperbaric Oxygen Therapy in Post Covid Condition

Self-administered versus Clinician-performed BinaxNOW COVID Rapid Test: A Comparison of Accuracy | The Impact of COVID-19 Vaccination Prior to SARS-CoV-2 Infection on Prevalence of Long COVID among a Population-based Probability Sample of Michiganders, 2020-2022 | Estimates of Incidence and Predictors of Fatiguing Illness after SARS-CoV-2 Infection | Long-term risks of Respiratory Diseases in Patients Infected with SARS-CoV-2

Early Estimates of Nirsevimab Immunoprophylaxis Effectiveness against Hospital Admission | Redirecting Antibody Responses from Egg-adapted Epitopes Following Repeat Vaccination | Risk of Cardiovascular Events after Influenza | Risk of Death Following Chikungunya Virus Disease | Comparative Effectiveness of Alternative Intervals Between First and Second Doses | Early Mortality After the First Dose of Coronavirus Disease

Estimating the Heritability of SARS-CoV-2 Susceptibility and COVID-19 Severity | Neonatal Outcomes After COVID-19 Vaccination in Pregnancy | Contralateral Second Dose Improves Antibody Responses to a Two-dose mRNA Vaccination Regimen | Substantial Health and Economic Burden of COVID-19 During the Year After Acute Illness Among US Adults Not at High Risk of Severe COVID-19

Efficacy and safety of respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons | Effectiveness of High-dose vs. Standard-dose Quadrivalent Influenza Vaccine against Recurrent Hospitalizations and Mortality in Relation to Influenza Circulation: A Post-hoc Analysis of the DANFLU-1 Randomized Clinical Trial